Literature DB >> 16520479

The growing menace of community-acquired methicillin-resistant Staphylococcus aureus.

Robert C Moellering.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16520479     DOI： 10.7326/0003-4819-144-5-200603070-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  32 in total

1.  Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.

Authors:  John D Szumowski; Daniel E Cohen; Fumihide Kanaya; Kenneth H Mayer
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Community-associated MRSA: superbug at our doorstep.

Authors:  Michael Hawkes; Michelle Barton; John Conly; Lindsay Nicolle; Clare Barry; Elizabeth L Ford-Jones
Journal:  CMAJ       Date:  2007-01-02       Impact factor: 8.262

3.  Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers.

Authors:  Michael W Ellis; Matthew E Griffith; James H Jorgensen; Duane R Hospenthal; Katrin Mende; Jan E Patterson
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

4.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  Optimization of the antimicrobial effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA) in vitro.

Authors:  Violet V Bumah; Daniela S Masson-Meyers; Susan Cashin; Chukuka S Enwemeka
Journal:  Lasers Surg Med       Date:  2015-01-12       Impact factor: 4.025

6.  Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.

Authors:  A Lepak; K Marchillo; J VanHecker; D Andes
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

7.  Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California.

Authors:  Lyndsey O Hudson; Courtney R Murphy; Brian G Spratt; Mark C Enright; Leah Terpstra; Adrijana Gombosev; Paul Hannah; Lydia Mikhail; Richard Alexander; Douglas F Moore; Susan S Huang
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

8.  Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities.

Authors:  Malcolm McDonald; Annette Dougall; Deborah Holt; Flavia Huygens; Frances Oppedisano; Philip M Giffard; John Inman-Bamber; Alex J Stephens; Rebecca Towers; Jonathan R Carapetis; Bart J Currie
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 9.  Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature.

Authors:  Andrew F Shorr
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 10.  New antimicrobial agents as therapy for resistant gram-positive cocci.

Authors:  J R Lentino; M Narita; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.